Cabot Wealth Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.07M | Sell |
5,470
-301
| -5% | -$193K | 0.35% | 62 |
|
|
2025
Q4 | $3.9M | Sell |
5,771
-69
| -1% | -$47K | 0.43% | 60 |
|
|
2025
Q3 | $3.73M | Sell |
5,840
-22
| -0.4% | -$13.4K | 0.41% | 60 |
|
|
2025
Q2 | $3.14M | Sell |
5,862
-12
| -0.2% | -$5.74K | 0.37% | 67 |
|
|
2025
Q1 | $2.47M | Buy |
5,874
+259
| +5% | +$112K | 0.31% | 71 |
|
|
2024
Q4 | $2.32M | Sell |
5,615
-100
| -2% | -$43.9K | 0.29% | 77 |
|
|
2024
Q3 | $2.89M | Buy |
5,715
+85
| +2% | +$41.3K | 0.36% | 69 |
|
|
2024
Q2 | $2.74M | Sell |
5,630
-11
| -0.2% | -$5.52K | 0.36% | 65 |
|
|
2024
Q1 | $3.05M | Sell |
5,641
-33
| -0.6% | -$18K | 0.4% | 60 |
|
|
2023
Q4 | $3.15M | Sell |
5,674
-97
| -2% | -$45.5K | 0.44% | 60 |
|
|
2023
Q3 | $2.52M | Buy |
5,771
+133
| +2% | +$66.3K | 0.39% | 65 |
|
|
2023
Q2 | $2.83M | Sell |
5,638
-125
| -2% | -$59.9K | 0.42% | 60 |
|
|
2023
Q1 | $2.88M | Sell |
5,763
-228
| -4% | -$109K | 0.46% | 57 |
|
|
2022
Q4 | $2.44M | Buy |
5,991
+2,260
| +61% | +$877K | 0.41% | 60 |
|
|
2022
Q3 | $1.22M | Sell |
3,731
-94
| -2% | -$34.5K | 0.21% | 85 |
|
|
2022
Q2 | $1.34M | Sell |
3,825
-49
| -1% | -$20K | 0.21% | 84 |
|
|
2022
Q1 | $2.12M | Buy |
3,874
+3
| +0.1% | +$1.58K | 0.29% | 81 |
|
|
2021
Q4 | $2.55M | Sell |
3,871
-12
| -0.3% | -$7.53K | 0.32% | 75 |
|
|
2021
Q3 | $2.42M | Sell |
3,883
-5
| -0.1% | -$3.36K | 0.32% | 71 |
|
|
2021
Q2 | $2.46M | Sell |
3,888
-66
| -2% | -$36.4K | 0.33% | 70 |
|
|
2021
Q1 | $1.94M | Buy |
3,954
+79
| +2% | +$39.6K | 0.27% | 77 |
|
|
2020
Q4 | $1.94M | Sell |
3,875
-9
| -0.2% | -$4.03K | 0.3% | 70 |
|
|
2020
Q3 | $1.53M | Sell |
3,884
-13
| -0.3% | -$4.81K | 0.28% | 73 |
|
|
2020
Q2 | $1.29M | Sell |
3,897
-140
| -3% | -$40.5K | 0.26% | 73 |
|
|
2020
Q1 | $978K | Sell |
4,037
-65
| -2% | -$17K | 0.23% | 76 |
|
|
2019
Q4 | $1.07M | Sell |
4,102
-94
| -2% | -$24.8K | 0.21% | 80 |
|
|
2019
Q3 | $1.14M | Sell |
4,196
-109
| -3% | -$30.3K | 0.24% | 78 |
|
|
2019
Q2 | $1.19M | Sell |
4,305
-4,604
| -52% | -$1.13M | 0.25% | 79 |
|
|
2019
Q1 | $1.99M | Sell |
8,909
-98
| -1% | -$20.2K | 0.44% | 62 |
|
|
2018
Q4 | $1.68M | Sell |
9,007
-92
| -1% | -$18.9K | 0.41% | 64 |
|
|
2018
Q3 | $2.27M | Sell |
9,099
-25
| -0.3% | -$6.07K | 0.49% | 62 |
|
|
2018
Q2 | $1.99M | Hold |
9,124
| – | – | 0.44% | 64 |
|
|
2018
Q1 | $1.75M | Buy |
9,124
+74
| +0.8% | +$13.7K | 0.39% | 65 |
|
|
2017
Q4 | $1.42M | Buy |
9,050
+309
| +4% | +$48.6K | 0.31% | 76 |
|
|
2017
Q3 | $1.36M | Buy |
+8,741
| New | +$1.38M | 0.31% | 76 |
|
Other funds holding IDXX
VCM
VPM
Cabot Wealth Management's IDXX Position: Q1 2026 in Review
Cabot Wealth Management reduced its Idexx Laboratories (IDXX) stake by 5.2% in Q1 2026, selling an estimated $193K and leaving 5,470 shares worth $3.07M. The position accounts for 0.35% of the portfolio, ranked #62.
Cabot Wealth Management first reported a position in IDXX in Q3 2017 and has held it in 35 quarters since. The position peaked at $3.9M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Cabot Wealth Management held 5,470 shares of Idexx Laboratories worth $3.07M as of Q1 2026.
- Cabot Wealth Management sold 301 Idexx Laboratories shares in Q1 2026, an estimated $193K.
- Idexx Laboratories made up 0.35% of Cabot Wealth Management's portfolio in Q1 2026, its #62 holding.
- Cabot Wealth Management first reported a position in Idexx Laboratories in Q3 2017 and has held it in 35 quarters since.
- Cabot Wealth Management's Idexx Laboratories position peaked at $3.9M in Q4 2025.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Cabot Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.